Evaluation of Diabetes Risk Models Applied to the Prediction of Incident Dysglycaemia in African and European Populations
Journal article, 2026

Aims: We evaluated overall and sex-specific performance of established diabetes risk models for predicting incident dysglycaemia in African and European populations. Materials and Methods: We externally evaluated the African Diabetes Risk model, Finnish Diabetes Risk model, Epidemiological Study on the Insulin Resistance Syndrome model and the personal and clinical Framingham models. Evaluation was performed in three prospective cohorts: the Research on Obesity and Diabetes among African Migrants (RODAM-Pros; migrant and non-migrant Ghanaians; n = 1607), the Middle-aged Soweto cohort (MASC; urban Black South Africans; n = 515) and the Västerbotten Intervention Programme (VIP; Sweden; n = 3044). Dysglycaemia was defined according to American Diabetes Association criteria. Discrimination (c-statistic) and calibration were assessed before and after recalibration. Results: Dysglycaemia developed in 17.7% of RODAM-Pros participants, 35.0% of MASC participants and 27.5% of VIP participants, with median follow-up of 6.7, 6.7 and 9.9 years, respectively. All models demonstrated poor-to-modest discrimination (c-statistic < 0.7). Most models substantially underestimated risk. Recalibration eliminated systematic miscalibration and reduced calibration error to ≤ 2.3% in RODAM-Pros and VIP and ≤ 3.4% in MASC. Performance varied by sex and cohort. Conclusions: Existing diabetes risk prediction models can be applied to predict incident dysglycaemia in both Sub-Saharan African and European populations, but only after recalibration to local risk levels.

calibration

sub-Saharan Africa

ethnicity

discrimination

prediction

incident dysglycaemia

Author

Melony Fortuin de Smidt

Umeå University

Patrik Wennberg

Umeå University

Hannah Maike Albers

University of Bonn

Charles Agyemang

University of Amsterdam

Felix P. Chilunga

University of Amsterdam

Rikard Landberg

Wallenberg Lab.

Chalmers, Life Sciences, Food and Nutrition Science

Lisa K. Micklesfield

University of Witwatersrand

Samuel N. Darko

Kwame Nkrumah University of Science and Technology

J. Otten

Umeå University

Ellis Owusu-Dabo

Kwame Nkrumah University of Science and Technology

Clemens Wittenbecher

SciLifeLab

Chalmers, Life Sciences, Food and Nutrition Science

Tommy Olsson

Stellenbosch University

Umeå University

Julia H. Goedecke

Umeå University

South African Medical Research Council

University of Witwatersrand

Ina Danquah

University of Bonn

Umeå University

Diabetes, Obesity and Metabolism

1462-8902 (ISSN) 1463-1326 (eISSN)

Vol. In Press

Omics approach for personalised prevention of type 2 diabetes mellitus for African and European Populations, OPTIMA

VINNOVA (2022-00547), 2022-11-21 -- 2025-12-31.

The metabolomics imprint of controlled modification of carbohydrate quality elucidates long-term impact on cardiometabolic disease risk and facilitates precision prevention approaches

Swedish Research Council (VR) (2022-01529), 2023-01-01 -- 2026-12-31.

Subject Categories (SSIF 2025)

Public Health, Global Health and Social Medicine

Endocrinology and Diabetes

DOI

10.1111/dom.71285

PubMed

42681823

More information

Latest update

9/11/2026